The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients

There are various melanoma treatment strategies that are based on immunological responses, among which immune checkpoint inhibitors (ICI) are relatively novel form. Nowadays, anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and anti-programmed death-1 (PD-1) antibodies represent a standard...

Full description

Bibliographic Details

Published in:	Life
Main Authors:	Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, Andrzej Mackiewicz
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Subjects:	biomarkers immunotherapy immune checkpoint inhibitors gut microbiota melanoma
Online Access:	https://www.mdpi.com/2075-1729/10/10/219